Alexandra Drakaki

17PUBLICATIONS
179CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 14, 2026
Immune biomarkers of response and resistance to ipilimumab and nivolumab in metastatic castration-resistant prostate cancer.

|Aug 18, 2026
Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|Jun 12, 2026
Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies.

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

Pageof 3

Frequent Collaborators

3 joint publications

Bradley McGregor

3 joint publications

Thomas Powles

3 joint publications

Toni K Choueiri

3 joint publications

Rana R McKay